Delivery Order SPE2DB20D3104-SPE2DB25FW0G2
- Not listed
- The Defense Logistics Agency awarded a $1,724.60 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Mesalamine DR 400 mg capsules (180 count). The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was not set aside for any particular business category and was competitively awarded...
- The Defense Logistics Agency awarded a delivery order valued at $3,353.73 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count) with a firm fixed price arrangement. The order was competitively awarded without set-aside designation and is scheduled for completion by September 2, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location, serving the federal government's...
- The Defense Logistics Agency awarded a delivery order valued at $2,830.02 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180 count) with an ultimate completion date of September 29, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a delivery order under AmerisourceBergen's larger indefinite delivery vehicle with the DLA. The product will be performed at the contractor's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $2,619.57 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count units). This contract type is a firm fixed-price delivery order with no set-aside designation, executed on June 17, 2025, with an ultimate completion date of June 18, 2025. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Mesalamine ER 0.375 gram capsules (120-count) with a ceiling value of $8,068.53. This firm fixed-price delivery order, which will be completed by September 10, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $17,820.21 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180-count units) with an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mesalamine is a pharmaceutical treatment primarily used for inflammatory bowel...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units) with a ceiling value of $14,764.20. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the open competition...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mesalamine DR 1.2 GM tablets (120-count supply) on September 18, 2025, with a ceiling value of $8,208.17 and an ultimate completion date of September 19, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Mesalamine DR 1.2 GM tablets in quantities of 60 units. This is a firm fixed-price delivery order with a ceiling value of $1,556.04, with an ultimate completion date of September 4, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,882.72 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 400 mg capsules (180 count) under a firm fixed price contract. The order was competitively awarded without a set-aside designation and is scheduled for completion by June 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery from its corporate office location. This...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FW0G2Delivery Order
The Defense Logistics Agency awarded a $4,252.56 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Mesalamine DR 400 mg capsules (180 count). This non-set-aside, competitively awarded contract is scheduled for completion by September 18, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government supporting military and veteran healthcare needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. As a prime vendor contract, the IDC enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's consistent receipt of competitive delivery orders under this vehicle demonstrates its capability to fulfill federal medical procurement requirements across multiple therapeutic domains and order values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 9/17/25 |